Markets:

Overview

News

Currencies

International

Treasuries

Scholar Rock Holding Corporation - Common Stock (NQ:SRRK)

46.30 -0.99 (-2.10%)

Streaming Delayed Price Updated: 3:13 PM EDT, Aug 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Scholar Rock Holding Corporation - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Where Scholar Rock Holding Stands With Analysts ↗

August 09, 2022

Analysts have provided the following ratings for Scholar Rock Holding (NASDAQ:SRRK) within the last quarter:

Via Benzinga

Scholar Rock Reports Second Quarter 2022 Financial Results and Highlights Business Progress

August 08, 2022

From Scholar Rock

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 08, 2022

Via Benzinga

Scholar Rock Announces the Addition of Srinivas Akkaraju, M.D., Ph.D. to Its Board of Directors

July 26, 2022

From Scholar Rock

Via Business Wire

5 Analysts Have This to Say About Scholar Rock Holding ↗

July 12, 2022

Scholar Rock Holding (NASDAQ:SRRK) has observed the following analyst ratings within the last quarter:

Via Benzinga

Where Scholar Rock Holding Stands With Analysts ↗

June 23, 2022

Scholar Rock Holding (NASDAQ:SRRK) has observed the following analyst ratings within the last quarter:

Via Benzinga

Why Scholar Rock Shares Are Trading Higher Today ↗

June 17, 2022

Via Benzinga

Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday ↗

August 08, 2022

Gainers

Via Benzinga

Scholar Rock to Participate in the 2022 Wedbush PacGrow Healthcare Conference

July 19, 2022

From Scholar Rock

Via Business Wire

Scholar Rock to Present New Preclinical Data on its Targeted Approach to the LTBP-TGFβ1 Complex for Anti-Fibrotic Therapy at the 2022 FASEB Science Research Conference

July 15, 2022

From Scholar Rock

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 12, 2022

Gainers Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022 ↗

July 12, 2022

Upgrades

Via Benzinga

The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill ↗

July 07, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Tesla, Twitter And 76 Biggest Movers From Friday ↗

July 11, 2022

Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...

Via Benzinga

Why Is DoorDash Down By 8%? 38 Stocks Moving In Wednesday's Mid-Day Session ↗

July 06, 2022

Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 69.5% to $2.1199 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change...

Via Benzinga

Coinbase, Moderna And 56 Biggest Movers From Yesterday ↗

July 07, 2022

Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time...

Via Benzinga

Scholar Rock to Present Phase 3 SAPPHIRE Trial Design at the 17th International Congress on Neuromuscular Diseases (ICNMD 2022)

July 01, 2022

From Scholar Rock

Via Business Wire

InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday ↗

June 29, 2022

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 28, 2022

Gainers

Via Benzinga

Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session ↗

June 28, 2022

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

45 Stocks Moving In Tuesday's Mid-Day Session ↗

June 21, 2022

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.

Via Benzinga

This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday ↗

June 28, 2022

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

67 Biggest Movers From Yesterday ↗

June 22, 2022

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.

Via Benzinga

Dow Jones Turns Lower; Revlon Shares Jump ↗

June 17, 2022

U.S. stocks pared gains midway through trading, with the Dow Jones dropping around 100 points on Friday.

Via Benzinga

89 Biggest Movers From Friday ↗

June 21, 2022

Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

33 Stocks Moving In Friday's Mid-Day Session ↗

June 17, 2022

Gainers Revlon, Inc. (NYSE: REV) gained 81.5% to $3.54 following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy.

Via Benzinga

The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease ↗

June 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

U.S. Markets Open Higher; Dow Rises Around 200 Points ↗

June 17, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Friday.

Via Benzinga

Scholar Rock Announces $205 Million Registered Direct Offering

June 17, 2022

From Scholar Rock

Via Business Wire

Positive Phase 2 Topaz Trial Extension Data Demonstrate Sizable and Sustained Motor Function Improvement at 24 Months with Apitegromab for Non-Ambulatory Patients with Types 2 and 3 Spinal Muscular Atrophy (SMA)

June 17, 2022

From Scholar Rock

Via Business Wire

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

FAQs about delivery changes

Scholar Rock Holding Corporation - Common Stock (NQ:SRRK)

All News about Scholar Rock Holding Corporation - Common Stock

The Newspapers of New England Family

We continue to need local support from our readers

FAQs about delivery changes

Scholar Rock Holding Corporation - Common Stock (NQ:SRRK)

All News about Scholar Rock Holding Corporation - Common Stock

Enjoying the Concord Monitor?

Sign in